Navigation Links
Gene therapy research from Penn Vet & Scheie Eye Inst. cures retinitis pigmentosa in dogs
Date:1/23/2012

therapeutic RPGR gene specifically to diseased rods and cones. In the absence of treatment, these cells malfunction and progressively die.

The research team has previously successfully applied a similar approach to two other heritable vision disorders that occur in both humans and dogs: Leber congenital amaurosis and achromatopsia. The present study was more challenging, as it was necessary to target both main classes of photoreceptor cells.

While the exact disease mechanism of the RPGR form of XLRP is still unknown, the researchers were able to successfully treat dogs with two different RPGR mutations. The mutations disrupt photoreceptors in different ways, but both ultimately cause them to become useless for vision. While this form of blindness is rare in dogs, it is common in humans. Patients with XLRP usually begin to lose night vision as children and become almost totally blind by middle age.

This is the first proof that this condition is treatable in an animal model; a single subretinal injection administered to the diseased dogs led to functional and structural recovery. The dogs' recovery was assessed using a variety of methods that are used clinically in patients, such as electroretinography and optical coherence tomography.

The researchers feel the results are promising and relevant for translation to the clinic.

"We are intervening to treat both classes of photoreceptor cells, rods and cones, and that has never been done before in a large animal model," Beltran said. "And not only can we prevent the disease onset but also restore the remaining photoreceptors cells to normal once the disease is ongoing."

While the ability to repair both rods and cones was itself a first, the research team went further, showing that its treatment also repaired the photoreceptor connections to other retinal neurons that eventually send visual signals to the brain, another first.

"This not only provides hope fo
'/>"/>

Contact: Evan Lerner
elerner@upenn.edu
215-573-6604
University of Pennsylvania
Source:Eurekalert

Page: 1 2 3

Related biology technology :

1. Lixte Biotechnology Holdings Announces Filing of a New Patent Application for Cancer Therapy Based on Targeting a Biomarker by Novel Investigational Agents
2. Reliant Technologies Announces Canadian Launch of Fraxel re:pair(R) Laser: A New Class of Treatment Therapy for CO2 Laser Skin Resurfacing
3. FDA Approves ALOXI(R) (Palonosetron HCl) Capsules for Prevention of Acute Chemotherapy-induced Nausea and Vomiting
4. Regenerative Medicine Appoints Cell Therapy Group Consultant to Editorial Board
5. Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery
6. Brain Cancer Patients at Two Leading Hospitals Treated Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems
7. Progenitor Cell Therapy Secures Industry Accreditation
8. Nucletron Announces Market Release of First Commercially Available Software to Review and Share Dicom-Based Treatment Plans for Radiotherapy
9. Doctors in the US and Netherlands Using Fast RapidArc Radiotherapy Technology to Help Fight Cancer are Now Treating Tumors of the Head and Neck
10. First Coast Oncology to Offer Next Generation Proton Therapy
11. Varian to Showcase RapidArc(TM) Radiotherapy Technology Enhancements at ASTRO 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 27, 2014 Rhythm, a biopharmaceutical company developing ... that result in metabolic disorders, announced today that it ... the U.S. Securities and Exchange Commission (SEC) relating to ... common stock. The number of shares to be offered ... yet been determined. Citigroup and Cowen and ...
(Date:8/27/2014)...   MSC , a healthcare performance improvement company ... appointment of Mary Beth Loesch to President ... experience preparing companies for rapid growth and market expansion, ... of Corporate Development and Healthcare. In that role, she ... well as corporate strategy and marketing. Previously, Loesch served ...
(Date:8/27/2014)... , Aug. 27, 2014 Reportlinker.com announces ... in its catalogue: Global Chelating Agents ... About Chelating Agent A chelating agent ... bonds with metal ions, thereby forming a metal-ion ... metal-ions have on chemical processes, formulations, and the ...
(Date:8/27/2014)... MADISON, N.J. , Aug. 27, 2014 /PRNewswire/ ... significant potential to help physicians better identify early-stage ... progression and disability, according to a new study ... from Quest Diagnostics (NYSE: DGX ) ... of the 14-3-3eta protein outperformed conventional antibody-serum testing, ...
Breaking Biology Technology:Rhythm Files Registration Statement for Proposed Initial Public Offering 2MSC names Mary Beth Loesch President and CEO 2Global Chelating Agents Market 2014-2018 2Global Chelating Agents Market 2014-2018 3Global Chelating Agents Market 2014-2018 4Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 2Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 3Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 4
... COUNTY, Calif., April 28 Beckman Coulter, Inc. (NYSE: ... manufacturer and marketer of products that simplify, automate and ... March 31, 2009 results. For the first quarter, ... in constant currency terms. On a constant currency ...
... SHPGY ), the global specialty biopharmaceutical company, announces that at its,Annual General Meeting today, all resolutions contained in the ... ... Against Withheld**, 1. To receive the, ... together with the, director,s and, ...
... CITY, April 28 /PRNewswire-FirstCall/ - Medicago Inc. (TSX-V: ... effective and affordable vaccines based on proprietary manufacturing ... it has received a genetic sequence of the ... recently been identified in USA and Mexico, and ...
Cached Biology Technology:Beckman Coulter Announces First Quarter 2009 Results 2Beckman Coulter Announces First Quarter 2009 Results 3Beckman Coulter Announces First Quarter 2009 Results 4Beckman Coulter Announces First Quarter 2009 Results 5Beckman Coulter Announces First Quarter 2009 Results 6Beckman Coulter Announces First Quarter 2009 Results 7Beckman Coulter Announces First Quarter 2009 Results 8Beckman Coulter Announces First Quarter 2009 Results 9Beckman Coulter Announces First Quarter 2009 Results 10Beckman Coulter Announces First Quarter 2009 Results 11Beckman Coulter Announces First Quarter 2009 Results 12Beckman Coulter Announces First Quarter 2009 Results 13Beckman Coulter Announces First Quarter 2009 Results 14Beckman Coulter Announces First Quarter 2009 Results 15Beckman Coulter Announces First Quarter 2009 Results 16Beckman Coulter Announces First Quarter 2009 Results 17Beckman Coulter Announces First Quarter 2009 Results 18Beckman Coulter Announces First Quarter 2009 Results 19Beckman Coulter Announces First Quarter 2009 Results 20Beckman Coulter Announces First Quarter 2009 Results 21Beckman Coulter Announces First Quarter 2009 Results 22Beckman Coulter Announces First Quarter 2009 Results 23Beckman Coulter Announces First Quarter 2009 Results 24Beckman Coulter Announces First Quarter 2009 Results 25Beckman Coulter Announces First Quarter 2009 Results 26Beckman Coulter Announces First Quarter 2009 Results 27Beckman Coulter Announces First Quarter 2009 Results 28Beckman Coulter Announces First Quarter 2009 Results 29Shire plc: Results of the Annual General Meeting Held on April 28, 2009 2Medicago initiates work on Swine Flu strain 2
(Date:8/27/2014)... DURHAM, N.C. -- When we want to listen carefully ... talking. The second thing we do is stop moving ... unwanted sounds generated by our own movements. , This ... deep in the brain. Indeed, indirect evidence has long ... somehow influences the auditory cortex, which gives rise to ...
(Date:8/27/2014)... release is available in German . ... is the most common inherited disease affecting the peripheral ... the Max Planck Institute of Experimental Medicine and University ... Schwann cells is impaired in rats with the disease. ... layer known as myelin, which facilitates the rapid transfer ...
(Date:8/27/2014)... fishing traps are lost or abandoned each year in ... traps, which continue to catch fish, crabs, and other ... to habitat, fisheries, and the watermen who depend on ... newly published NOAA study. , The report, published in ... of its kind to examine the derelict fish trap ...
Breaking Biology News(10 mins):Stop and listen: Study shows how movement affects hearing 2Stop and listen: Study shows how movement affects hearing 3Potential therapy for incurable Charcot-Marie-Tooth disease 2NOAA's Marine Debris Program reports on the national issue of derelict fishing traps 2
... DC Fascinating scientific advances across the spectrum ... be featured and explained through engaging table-top exhibits ... 15th Annual Exhibition & Reception. The exhibition/reception will ... March 24, in Rooms B338-340 of the Rayburn ...
... Alzheimer,s disease drugs currently studied in clinical trials appears ... animals, researchers at Georgetown University Medical Center report in ... . They say the results suggest that this ... drug has been able to do-- prevent the long-term ...
... Researchers at Memorial Sloan-Kettering Cancer Center (MSKCC) have shown ... some blood disorders may be inherited. Their research, published ... common genetic sequence abnormality that enhances the likelihood of ... blood diseases. The investigators carried out a genome-wide ...
Cached Biology News:Science returns to the Capitol Hill spotlight at March 24 exhibition 2Science returns to the Capitol Hill spotlight at March 24 exhibition 3Science returns to the Capitol Hill spotlight at March 24 exhibition 4Alzheimer's disease therapeutic prevents long-term damage from TBI in pre-clinical studies 2Alzheimer's disease therapeutic prevents long-term damage from TBI in pre-clinical studies 3
TNF-R2 (L-20)...
50 assays. Provides an easy system for rapid separation of cytosol and particulate fractions that are compatiable with downstream studies....
Highly sensive assay for detecting apoptosis in living cells. See detailed descriptions above in K250-25....
Eliminate electrical interference from any analog signal, without filtering. Ideal for electrophysiology applications like EKG, EMG, and EEGs. Removes 50/60hz noise and harmonics caused by grounding ...
Biology Products: